Sonolisib Completed Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01331083A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer